Already holding a PharmD, I obtained my Ph.D in molecular modeling (CADD, Computer Aided Drug Design) at the University of Strasbourg in 2006. I worked for AliX Pharma and then NovAliX for 8 years (2006-2014) as Head of the Molecular Modeling department. My work was focused on protein-ligand interactions to help the identification of most promising hits, in diverse therapeutic area, having experimental validation always in mind. I confirmed my skills in virtual screening (structure- and ligand-based), lead optimisation and fragment-based drug design, working closely with medicinal chemists and structural biologists. I am also familiar with chemical libraries management. I lead the scientific group, cornerstone of the BIONEXT’s offer.